AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
XELB
Xcel Brands, Inc.
There isn't enough reported data to score XELB yet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
XELB Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Strong |
XELB's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
XELB PE Valuation
XELB has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
XELB Forward outlook
There aren't enough analyst estimates for XELB to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the stronger earnings trend. Trailing diluted EPS is up 75% for AMZN versus XELB down 236%.
XELB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$14.01 | -$3.71 |
| Q2 2025 | -$15.89 | -$6.89 |
| Q1 2025 | -$14.13 | -$3.23 |
| Q4 2024 | -$16.05 | -$5.35 |
| Q3 2024 | -$10.30 | -$0.10 |
| Q2 2024 | -$9.00 | +$0.70 |
| Q1 2024 | -$10.90 | -$7.80 |
| Q4 2023 | -$10.70 | -$8.70 |
XELB lost $14.01 per share over the past year, a bigger loss than the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over XELB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over XELB on profitability, with a higher operating margin.
XELB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.1M | -15% |
| Q1 2026 | $1.1M | -14% |
| Q4 2025 | $1.2M | -3.4% |
| Q3 2025 | $1.1M | -42% |
| Q2 2025 | $1.3M | -55% |
| Q1 2025 | $1.3M | -39% |
| Q4 2024 | $1.2M | -47% |
| Q3 2024 | $1.9M | -27% |
XELB's revenue has slid since its 2019 peak: $1M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -141% | -16 points |
| Q1 2026 | -165% | -0.5 points |
| Q4 2025 | -167% | +366 points |
| Q3 2025 | -666% | -191 points |
| Q2 2025 | -125% | -136 points |
| Q1 2025 | -164% | +120 points |
| Q4 2024 | -533% | -287 points |
| Q3 2024 | -475% | -270 points |
XELB's operating margin was −141% last quarter, down 16 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
XELB has the stronger cash trend. Its trailing FCF is down 16% versus its history, compared with AMZN at down 619%.
XELB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.8M | -$418K |
| Q3 2025 | -$1.4M | -$966K |
| Q4 2024 | -$1.4M | +$2.3M |
| Q3 2024 | -$432K | +$913K |
| Q4 2023 | -$3.7M | -$571K |
| Q3 2023 | -$1.3M | +$1.1M |
| Q2 2023 | $1.4M | +$9.3M |
| Q1 2023 | -$3M | -$2.1M |
XELB has burned cash in most quarters: −$7M over the past year, against −$7M the year before.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over XELB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
XELB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.3% | +256K shares |
| 1 year | +159% | +3.8M shares |
| 3 years | +214% | +4.2M shares |
| 5 years | +220% | +4.2M shares |
| Available history | +225% | +4.3M shares |
XELB has 6M diluted shares, up 159% from a year ago, despite $190,000 in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $56,000 |
| Q1 2026 | $46,000 |
| Q4 2025 | $82,000 |
| Q3 2025 | $6,000 |
| Q2 2025 | $58,000 |
| Q1 2025 | $58,000 |
| Q4 2022 | — |
| Q3 2022 | — |
XELB spent $190,000 buying back its own shares over the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
XELB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2023 | -0.8x | Net Cash |
| Q4 2019 | 11.0x | High |
| Q3 2019 | 1.9x | Healthy |
XELB has more cash than debt.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
XELB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.2 | Oversold |
| Stochastic | 11.5 | Oversold |
XELB's weekly RSI is 27 (oversold) and its Stochastic is 12 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
XELB PE vs Consumer Cyclical Sector
| Metric | XELB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
XELB has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over XELB on trend strength, trading above more of its moving averages.
XELB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.50 | 30% below |
| 20 week MA | $0.88 | 60% below |
| 50 week MA | $1.36 | 74% below |
| 100 week MA | $1.87 | 81% below |
| 200 week MA | $5.57 | 94% below |
XELB is in a downtrend: it's below all five of its weekly moving averages, and 94% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over XELB on returns for 2026, with the stronger performance.
XELB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.0 | $11.4 | -29% |
| 2021 | $11.4 | $12.0 | +5.3% |
| 2022 | $12.0 | $7.40 | -38% |
| 2023 | $7.40 | $12.9 | +74% |
| 2024 | $12.9 | $4.85 | -62% |
| 2025 | $4.85 | $1.37 | -72% |
| 2026 YTD | $1.37 | $0.35 | -74% |
XELB has finished lower in four of the last six years. It's down 74% so far in 2026.